CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.

Regulatory T cell-based immunotherapy approved for use in matched-donor HSCTs ...

A landmark study due to start in the coming months aims to test a method for rejuvenating our immune system in older age. The ...

T cells are an elite fighting force of the immune system, seeking out and destroying diseased cells. But in a prolonged ...

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National Hospital using a ...

Summary: Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of liquid blood cancers by engineering a patient’s own immune cells to destroy malignant targets, replicating ...

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...

A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...

As high-parameter T-cell profiling becomes increasingly central to translational research and biomarker discovery, there is ...

There is a constant war going on in your body. Working against you are viruses and cancer cells growing uncontrollably, threatening your tissues and organs. Fighting on your side are immune cells such ...